Development of an in vivo model of human multiple myeloma bone disease

Blood

Volumn 87, Issue 4, 1996, Pages 1495-1501

  Alsina, Melissa ^a   Boyce, Brendan ^a   Devlin, Rowena D ^a   Anderson, Judith L ^a   Craig, Fiona ^a   Mundy, Gregory R ^a   Roodman, G David ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DESTRUCTION; BONE PAIN; CALCIUM CELL LEVEL; COLONY FORMING UNIT GM; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; HUMAN CELL; HYPERCALCEMIA; MOUSE; MULTIPLE MYELOMA; NONHUMAN; OSTEOCLAST; PARAPLEGIA; PATHOLOGIC FRACTURE; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; RAT;

EID: 0030019981     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1495.bloodjournal8741495     Document Type: Article

References (24)

1. Mundy GR, Bertolini DR: Bone destruction and hypercalcemia in plasma cell myeloma. Semin Oncol 3.291, 1986
2. Bataille R, Chappard D, Klein B: Mechanisms of bone lesions in multiple myeloma. Hematol Oncol Clin North Am 6:285, 1992
3. Taube T, Beneton MN, McCloskey EV, Rogers S, Greaves M, Kanis JA: Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. Eur J Haematol 49:192, 1992
4. Huang TW, Richardson JA, Tong AW, Zhang BQ, Stone MJ, Vitetta ES: Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res 53:1392, 1993
5. Raisz LG, Neimann I: Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology 85:446, 1969
6. Gowen M, Meikle MC, Reynolds JJ: Stimulation of bone resorption in vitro by a non-prostanoid factor released by human monocytes in culture. Biochim Biophys Acta 762:471, 1983
7. MacLennan IC, Drayson M, Dunn J: Multiple myeloma (review). Br Med J 308:1033, 1994
8. Bataille R, Chappard D, Alexandre C, Sany J: Importance of quantitative histology of bone changes in monoclonal gammopathy. Br J Cancer 53:805, 1986
9. Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, Alexandre C: Mechanism of bone destruction in multiple myeloma. The importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol 7:1909, 1989
10. Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon SE: Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 291:1041, 1974
11. Kawano M, Tanaka H: Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 73:2145, 1989
12. Garrett IR, Durie BGM, Nedwin GE, Gillespie A, Bringman T, Sabatini M, Bertolini DR, Mundy GR: Production of the bone resorbing cytokine lymphotoxin by cultured human myeloma cells. N Engl J Med 317:526, 1987
13. Cozzolino F, Torua M: Production of interleukin-1 by bone marrow myeloma cells. Blood 74:380, 1989
14. Klein B, Bataille R: Cytokine network in human multiple myeloma. Hematol Oncol Clin North Am 6:273, 1992
15. Bataille R, Jourdan M, Zhang XG, Klein B: Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. J Clin Invest 84:2008, 1989
16. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD: IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol 144:4226, 1990
17. De La Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GF, Roodman GD: IL-6 enhances hypercalcemia and bone resorption mediated by PTH-rP in vivo. J Clin Invest 95:2846, 1995
18. Linkhart TA, Linkhart SG, Strong DD: Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in normal human osteoblast-like cells: Regulation by interleukin-1. J Bone Miner Res 6:1285, 1991
19. Croese JW, Vas Nunes CM, Radl J, van den Enden-Vieveen MH, Brondijk RJ, Boersma WJ: The 5T2 mouse multiple myeloma model: Characterization of 5T2 cells within the bone marrow. Br J Cancer 56:555, 1987
20. Radl J, Croese JW, Zurcher C, van den Enden-Vieveen MH, de Leeuw AM: Animal model of human disease. Multiple myeloma. Am J Pathol 132:593, 1988
21. Feo-Zuppardi FJ, Taylor CW, Iwato K, Lopez MHA, Grogan TM, Odeleye A, Hersh EM, Salmon SE: Long-term engraftment of fresh human myeloma cells in SCID mice. Blood 80:2843, 1192
22. Valeriote F, Grates H: MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myeloma. J Natl Cancer Inst 76:61, 1986
23. Uy HL, Dallas M, Calland JW, Boyce BF, Mundy GR, Roodman GD: Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. J Bone Miner Res 10:295, 1995
24. Kurihara N, Chenu C, Miller M, Civin CI, Roodman GD: Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term marrow cultures. Endocrinology 126:2733, 1990